BIB
ETFProShares Ultra Nasdaq Biotechnology · NASDAQ
BIB is an ETF, not a company. An exchange-traded fund holds a basket of assets and trades like a stock.
ProShares Ultra Nasdaq Biotechnology (BIB) is an exchange-traded fund (ETF) listed on NASDAQ. There were no new wire items for BIB in the last 30 days. The most recent was published Feb 20, 2023.
Latest news
2 items- NEWSMan in Germany Cured of HIV After Undergoing Stem Cell Transplant, According to Report in Nature Medicinehttps://www.dailymail.co.uk/health/article-11772327/Man-CURED-HIV-D-sseldorf-patient-virus-free.html?ito=social-twitter_mailonline https://www.nature.com/articles/s41591-023-02213-x
- NEWSPsychedelics Company COMPASS Pathways To Join NASDAQ Biotechnology IndexPsilocybin-focused mental health care company COMPASS Pathways plc (NASDAQ:CMPS) revealed Friday that it has been selected for addition to the Nasdaq Biotechnology Index (NASDAQ:NBI), effective as of market open on Monday, Dec. 20. “We are proud to announce our addition to the esteemed Nasdaq Biotechnology Index,” George Goldsmith, CEO and founder of Compass Pathways said. “Our inclusion in this index enables us to reach new audiences as we continue to execute on our clinical development of our investigational COMP360 psilocybin therapy in hopes of addressing the most challenging issues in mental healthcare.” The NBI is designed to track the performance of a set of securities listed on the
BIB FAQ
7 questionsWhat does ProShares Ultra Nasdaq Biotechnology do?
The investment seeks daily investment results that correspond to two times (2x) the daily performance of the Nasdaq Biotechnology Index®. The fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the fund's investment objective. The index is a modified capitalization weighted index that includes securities of Nasdaq listed companies that are classified as either biotechnology or pharmaceutical. The fund is non-diversified.What is the latest news on BIB?
Quantisnow has not tracked any new filings, ratings or press releases for BIB in the last 30 days. The most recent wire item was published on February 20, 2023.Where does BIB stock trade?
ProShares Ultra Nasdaq Biotechnology (BIB) is listed on NASDAQ.What sector and industry is BIB in?
ProShares Ultra Nasdaq Biotechnology operates in the n/a sector.When did ProShares Ultra Nasdaq Biotechnology go public?
ProShares Ultra Nasdaq Biotechnology (BIB) completed its IPO in n/a.What companies are similar to BIB?
Notable peers in the same industry include HCXY (Hercules Capital, Inc.), ACCP (Accelerated Pharma, Inc.), ACLL (ACell, Inc.), DWEQ (AdvisorShares Dorsey Wright Alpha Equal Weight ETF), DWAW (AdvisorShares Dorsey Wright FSM All Cap World ETF). Compare BIB side-by-side with any of them on Quantisnow.How can I track BIB on Quantisnow?
Quantisnow aggregates ProShares Ultra Nasdaq Biotechnology's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow BIB to receive live email and push alerts on every new disclosure.